Skip to main content
Log in

Amrubicin

First report of interstitial lung disease: 7 patients

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Yoh K, Kenmotsu H, Yamaguchi Y, Kubota K, Ohmatsu H, Goto K, Niho S, Ohe Y, Saijo N, Nishiwaki Y.Severe interstitial lung disease associated with amrubicin treatment. Journal of Thoracic Oncology 5: 1435-1438, No. 9, Sep 2010. Available from: URL: http://dx.doi.org/10.1097/jto.0b013e3181e369a8 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amrubicin. React. Wkly. 1324, 11 (2010). https://doi.org/10.2165/00128415-201013240-00027

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013240-00027

Keywords

Navigation